I'm sure every investor wants to make good returns from their portfolio. Some ASX shares could be more undervalued than others and deliver stronger returns in a relatively short amount of time.
Some analysts think certain stocks can rise by more than 50% in the next year, though those returns are not guaranteed.
Below could be two of the most promising ideas on the ASX today.
Image source: Getty Images
Bubs Australia Ltd (ASX: BUB)
Bubs describes itself as a leading infant nutrition company that's "committed to providing premium-quality products that support the health and well-being of babies worldwide".
In other words, it's known for infant formula, including goat milk and grass-fed options. It has a presence in Australia, the US and growing international markets, including China.
The ASX share generated net revenue of $102.5 million in FY25 and it expects to reach FY26 revenue of between $105 million to $115 million, despite headwinds from challenging external market conditions.
It also expects to generate underlying operating profit (underlying EBITDA) of between $4 million to $8 million, despite evolving regulatory requirements, product availability constraints, geopolitical disruption in the Middle East, increased use of air freight to support re-stocking, and competitive pressures.
Bubs is focused on expanding distribution and marketing to potential customers. The US remains its strongest growth market and a key part of its strategy. It's concluding the use of air freight to restock the US. It says it's on track to achieve ranging in more than 10,000 stores in July 2026.
According to CMC Invest, of three analyst ratings within the last three months, the average price target is 15 cents. At the time of writing, that implies a possible rise of 63%. It's valued at 15x FY28's estimated earnings.
Objective Corporation Ltd (ASX: OCL)
The other ASX share I'll highlight today is Objective Corporation, a software business that has enabled thousands of public sector organisations to shift to digital operations.
While the ASX share is not growing at a rapid speed, it's expanding at a pleasing rate for compounding. In the FY26 half-year result, it revealed revenue growth of 9% to $66.7 million, with annualised recurring revenue (ARR) growth of 12% to $120 million.
Profit is increasing at a faster pace than revenue – I love seeing rising profit margins. Adjusted operating profit (EBITDA) grew 11% to $25.9 million and net profit rose 10% to $18.7 million.
According to CMC Invest, there have been three recent ratings on the business, with an average price target of $16.93, suggesting a possible rise of 62%. It's valued at 21x FY28's estimated earnings, according to the forecast on CMC Invest.
